Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

AMGEN INC.

(AMGN)
  Rapport
Vertraagde tijd Nasdaq  -  19:00 25-11-2022
283.74 USD   +0.12%
22/11Amneal Pharmaceuticals lanceert Releuko voor neutropenie in de VS
MT
22/11Amgen's osteoporosemedicijn Prolia wordt door de Amerikaanse FDA onderzocht op het risico van ernstige hypocalcemie bij dialysepatiënten.
MT
22/11Amgen's osteoporosemedicijn Prolia wordt door de Amerikaanse FDA onderzocht op het risico van ernstige hypocalcemie bij dialysepatiënten.
MT
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Communiquťs de presse de la sociťtť AMGEN INC.
24/11U.S. Supreme Court To Decide On Enablement Standard For Biotech Antibody Patents In Amg..
AQ
23/11Amgen announces webcast of 2022 evercore isi healthcare conference
PR
17/11USSC Agrees To Reconsider Amgen Inc. V Sanofi On Enablement Of Antibody Genus Claims
AQ
14/11Supreme Court To Consider Enablement Requirement
AQ
11/11Amgen v. Sanofi Case On Enablement Of Antibody Genus Claims Will Be Heard At The Suprem..
AQ
10/11Amgen : Latest Acquisition Puts a Spotlight on Rare Autoimmune Disease
PU
10/11Supreme Court To Address What It Means To Have An Enabling Disclosure
AQ
07/11Amgen announces webcast of 2022 credit suisse global healthcare conference
AQ
04/11Amgen announces webcast of 2022 credit suisse global healthcare conference
PR
04/11AMGEN INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF ..
AQ
03/11Amgen : Q3 Earnings Snapshot
AQ
31/10Amgen announces webcast of 2022 third quarter financial results
PR
28/10Amgen announces 2022 fourth quarter dividend
PR
27/10Amgen : Staff Around the World Volunteer for International Coastal Cleanup
PU
26/10Amgen : Five Takeaways from Amgen's Roundtable on Climate Change and Human Health
PU
20/10Amgen Inc : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
17/10Amgen Releases 2022 Biosimilar Trends Report
AQ
13/10Amgen : Recognizing National Disability Employment Awareness Month
PU
12/10Amgen : Follow the Data
PU
12/10BridgeBio Pharma Announces First Lung Cancer Patient Dosed in Phase 1/2 Trial and US FD..
AQ
12/10Amgen's annual trends report finds competition created by biosimilars contributed $21 b..
PR
06/10Amgen : Officially Opens New State-Of-The-Art R&D Site In San Francisco
PU
06/10Amgen opens new state-of-the-art research and development laboratory site in san franci..
PR
16/09Amgen : Is Ready to Meet Growing Demand for Innovative Medicines, Says Bradway in Bloomber..
PU
13/09Asthma Peak Week : What You Need to Know About Indoor Air Pollution
PU
12/09Amgen announces webcast of 2022 bank of america merrill lynch global healthcare confere..
PR
12/09Lumakrasģ (sotorasib) combined with vectibixģ (panitumumab) shows confirmed 30% objecti..
PR
09/09Amgen announces positive new data at eadv 2022 for otezla
AQ
08/09Amgen announces webcast of 2022 morgan stanley global healthcare conference
PR
08/09Amgen announces positive new data at eadv 2022 for otezlaģ (apremilast)
PR
07/09Amgen to webcast investor call at esmo 2022
PR
02/09Amgen announces webcast of 2022 wells fargo healthcare conference
PR
02/09Amgen announces webcast of 2022 citi global healthcare conference
PR
31/08Amgen announces topline data from lumakras phase 3 trial in non-small cell lung cancer
AQ
30/08Amgen to present new, positive clinical and real-world data across inflammation portfol..
PR
25/08Amgen : How Genetic Validation Helped Innovate Medicine for Patients with High Cholesterol
PU
23/08Amgen announces positive top-line results from phase 3 study of abp 959, biosimilar can..
PR
22/08Amgen to present new data at esc congress 2022 highlighting up to 8.5 years of repathaģ..
PR
18/08Amgen Inc : Entry into a Material Definitive Agreement, Financial Statements and Exhibits ..
AQ
16/08Amgen : Statement on Drug Pricing Provisions Included in “Inflation Reduction Act&rd..
PU
16/08Amgen Chronicles : Fresh Water and Fresher Ideas About Sustainability in Puerto Rico
PU
13/08Amgen : Statement on Drug Pricing Provisions Included in “Inflation Reduction Act&rd..
PU
09/08Amgen : Statement on Drug Pricing Provisions Included in “Inflation Reduction Act&rd..
PU
05/08Amgen reports second quarter 2022 financial results
AQ
05/08AMGEN INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF ..
AQ
04/08Amgen : REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS - Form 8-K
PU
04/08Amgen : Q2 Earnings Snapshot
AQ
04/08Amgen : TO ACQUIRE CHEMOCENTRYX FOR $4 BILLION IN CASH - Form 8-K
PU
04/08Amgen Inc : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financia..
AQ
03/08Amgen : APPOINTS MICHAEL V. DRAKE TO BOARD OF DIRECTORS - Form 8-K
PU
03/08Amgen Inc : Change in Directors or Principal Officers, Financial Statements and Exhibits (..
AQ
03/08Amgen appoints michael v. drake to board of directors
PR
03/08Amgen announces 2022 third quarter dividend
PR
02/08Amgen to webcast investor meeting at wclc 2022
PR
01/08Amgen announces webcast of 2022 second quarter financial results
PR
20/07Amgen : Amid "The Great Resignation" Why Some Amgen Employees Stayed
PU
07/07Amgen Releases Preview Of 2022 Trends In Biosimilars Report
AQ
10/06Amgen announces webcast of goldman sachs 43rd annual healthcare conference
PR
09/06Behind One Biotech's Water Conservat : Saving Every Drop
PU
07/06Amgen - FDA APPROVES RIABNI (RITUXIMAB-ARRX), A BIOSIMILAR TO RITUXAN (RITUXIMAB), FOR ..
AQ
06/06New Bpcia Complaint : Genentech Files Suit Against Tanvex Regarding Its Proposed Herceptin..
AQ
06/06FDA APPROVES RIABNI™ (RITUXIMAB-ARRX), A BIOSIMILAR TO RITUXANģ (RITUXIMAB), FOR ..
PR
03/06Amgen announces webcast of 2022 jefferies healthcare conference
PR
03/06Regeneron Files Antitrust Lawsuit Accusing Amgen Of Engaging In A Persistent Exclusiona..
AQ
02/06Amgen : Statement on Russia/Ukraine
PU
31/05AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 2 DATA FOR INVESTIGATIONAL OLPASIRAN IN ADULTS W..
PR
18/05Amgen Inc : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
12/05Amgen and lance bass partner to encourage people to do a 'double take' to recognize the..
PR
09/05Amgen announces webcast of 2022 bank of america healthcare conference
AQ
06/05Amgen announces webcast of 2022 bank of america healthcare conference
PR
04/05Will The Supreme Court Take The Bait? CVSG Issued And Other Updates In The Amgen v. San..
AQ
02/05Amgen releases annual environmental, social & governance report
PR
28/04AMGEN INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF ..
AQ
28/04Amgen : REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS - Form 8-K
PU
27/04Amgen : Q1 Earnings Snapshot
AQ
1  2  3  4  5  6  7  8  9  10Volgende